2627
Compound 1 is a potent A ( 2A ) / A ( 1 ) receptor antagonist in vitro ( A ( 2A ) K ( i ) = 4 . 1 nM ; A ( 1 ) K ( i ) = 17 . 0 nM ) that has excellent activity , after oral administration , across a number of animal models of Parkinson ' s disease including mouse and rat models of haloperidol - induced catalepsy , mouse model of reserpine - induced akinesia , rat 6 - hydroxydopamine ( 6 - OHDA ) lesion model of drug - induced rotation , and MPTP - treated non - human primate model .
 Disease: Parkinson ' s disease; Chemical: haloperidol; Disease: catalepsy; Chemical: reserpine; Disease: akinesia; Chemical: 6 - hydroxydopamine; Chemical: 6 - OHDA; Chemical: MPTP
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Disease: Parkinson ' s disease; Chemical: haloperidol; Disease: catalepsy; Chemical: reserpine; Disease: akinesia; Chemical: 6 - hydroxydopamine; Chemical: 6 - OHDA; Chemical: MPTP